The novel vaccine delivery devices market is estimated to be worth USD 1.5 billion in 2030\RootsAnalysis
Owning to a varietyof relevant reasons, which include trypanophobia and dependence on the coldchain, there is an evident demand for innovative and user-friendly vaccinedelivery systems that are also safe and efficient
Roots Analysis is pleased toannounce the publication of its recent study, titled, “NovelVaccine Delivery Devices Market, 2019-2030”.
The report features an extensive study of thecurrent landscape and the likely future opportunities associated with novelvaccine delivery devices, over the next 10-12 years. Amongst other elements,the report includes:
§ A detailed assessmentof the overall novel vaccine delivery devices market landscape, featuring anelaborate list of device developers engaged in the development of novel vaccinedelivery devices.
§ A detailedcompetitiveness analysis of novel vaccine delivery devices, taking intoconsideration the supplier power and key product specifications.
§ An analysisevaluating the effectiveness of various vaccines delivery devices in order tocompare their respective strengths and capabilities based on a variety ofparameters.
§ A detailed list ofmarketed and pipeline vaccine candidates that are anticipated to be developedin combination with novel vaccine delivery devices in the near future.
§ Elaborate profiles ofprominent product developers engaged in the novel vaccine delivery devicesdomain (shortlisted on the basis of the number of pipeline products).
§ An analysis of thepartnerships that have been established in this domain, in the recent past.
§ A discussion onimportant, industry-specific trends, key market drivers and challenges, under acomprehensive SWOT framework.
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
- Global Novel Vaccine Delivery Devices (By Value)
§ Type of Device
§ Electroporation-basedNeedle Free Injection Systems
§ Oral Delivery Systems
§ Nasal DeliverySystems
§ Jet Injectors
§ Microneedle Patches
§ Microinjectors
§ Route ofAdministration
§ Oral
§ Intramuscular
§ Intranasal
§ Intradermal
§ Subcutaneous
§ Type of Vaccines
§ Bivalent Oral PolioVaccine
§ BCG Vaccine
§ DTP-HepB-Hib Vaccine
§ PneumococcalConjugate Vaccine
§ Influenza Vaccine
§ Measles Vaccine
§ Tetanus-DiphtheriaVaccine
§ Others
§ Key GeographicalRegion
- North America
- Europe
- Asia Pacific
- Rest of the World
Keycompanies covered in the report
§ 3M
§ Becton Dickinson
§ Consort Medical
§ D’Antonio ConsultantsInternational
§ Enesi Pharma
§ Ichor Medical
§ Iconovo
§ InovioPharmaceuticals
§ PharmaJet
§ Union Medico
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html or email sales@rootsanalysis.com
You may also be interested in the followingtitles:
1. Microneedlesand Needle-Free Injection Systems / JetInjectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030
2. SubcutaneousBiologics, Technologies and Drug Delivery Systems(2nd Edition), 2018-2030
3. LargeVolume Wearable Injectors Market (4th Edition),2018-2030
4. GlobalAutoinjectors Market (2nd Edition), 2018-2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
